Home > Newsletters > Drug Industry Daily > Track-and-Trace System Is No Substitute for Drug Pedigrees to Thwart Gray Market, Lawmakers Say
Drug Industry Daily
June 13, 2012 | Vol. 11 No. 116
Track-and-Trace System Is No Substitute for Drug Pedigrees to Thwart Gray Market, Lawmakers Say
Some Democratic lawmakers are pushing for a drug pedigree system to combat potential “gray marketing” of shortage drugs, arguing that a national track-and-trace system would not be enough to secure the supply chain.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.